Information Library
Results for: White Papers - Faster product development - Our Expertise
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Pharmacobiomics and Infectious Disease: Progress and Opportunities
November 2, 2010
Pharmacobiomics and Infectious Disease: Progress Opportunities. After decades of work mapping the human genome, we are beginning to reap real benefits. -
Advancing Clinical Research in Alzheimer's Disease
October 18, 2010
This report from Quintiles’ own Alzheimer’s experts gives you an inside look at the news from ICAD 2010. -
Is a REMS Request from FDA More Likely for Drugs & Biologics Indicated for Pediatric Use?
October 8, 2010
Is a REMS Request From FDA More Likely For Drugs and Biologics Indicated for Pediatric Use? -
Using Real-Time Data to Drive Better Decisions, Faster
September 30, 2010
This white paper examines the advantages afforded by access to real-time data during the course of a clinical trial. -
Navigating Future Challenges in Alzheimer's Disease Trials
September 21, 2010
Quintiles’ own Alzheimer’s experts, Amir Kalali, Roza Hayduk and Lynne Hughes, sum up the insights and discoveries that could lead to the next breakthrough for Alzheimer’s disease. -
Mapping the Future in Oncology Drug Development
August 27, 2010
Industry veterans Harish Dave and Eric Groves summarize key findings of Quintiles’ ASCO Ancillary Event, Mapping the Future in Oncology Drug Development -
FDA Requirements for Clinical Studies in Pediatric Patients
April 1, 2010
FDA Requirements for Clinical Studies in Pediatric Patients FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy -
Integration of Molecular Biomarkers into Clinical Development
March 29, 2010
Examining the challenges and opportunities in co-developing a biomarker and drug, this is the first white paper in a new series focusing on oncology. -
Data-Driven Patient Recruitment
March 23, 2010
Under pressure to deliver more evidence faster, drug developers are constantly searching for more patients for clinical trials. -
Regulations for Clinical Studies in Pediatric Patients in the European Union
March 10, 2010
After the United States issued pediatric drug study requirements, the European Union (EU) passed a regulation that created major changes to clinical studies for pediatric
